Studies have proved that rTMS reduces neuroinflammation by inhibiting microglial polarization and decreasing inflammatory cytokines (e.g., TNF-α, IL-1β, and IL-6), thus alleviating pain symptoms in HSP patients [22]. Here, TNF is linked to hereditary spastic paraplegia.